KMTS - Kestra Medical Technologies, Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$24.00
DETAILS
HIGH:
$24.00
LOW:
$24.00
MEDIAN:
$24.00
CONSENSUS:
$24.00
DOWNSIDE:
9.19%
| Metric | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | 59.8 | 27.8 | 7.6 | 0 | 0 |
| Cost of Revenue | 35.6 | 27.5 | 18.3 | 0 | 0 |
| Gross Profit | 24.2 | 0.4 | (10.7) | 0 | 0 |
| Operating Expenses | |||||
| R&D Expenses | 15.7 | 15.5 | 15.8 | 18.8 | 22.8 |
| SG&A Expenses | 114.9 | 69.9 | 54.0 | 13.9 | 6.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 130.6 | 85.4 | 69.8 | 32.7 | 29.3 |
| Operating Income | |||||
| Operating Income | (106.4) | (85.1) | (80.4) | (32.7) | (29.3) |
| Interest Expense | 7.7 | 6.2 | 5.6 | 1.2 | 0 |
| Interest Income | 3.2 | 0 | 0 | 0 | 0 |
| Profitability | |||||
| EBITDA | (98.0) | (76.3) | (73.7) | (32.3) | (28.8) |
| EBIT | (105.9) | (87.9) | (78.6) | (32.7) | (29.3) |
| Income Before Tax | (113.7) | (94.1) | (84.2) | (33.9) | (29.3) |
| Income Tax Expense | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 |
| Net Income | (113.8) | (94.1) | (84.2) | (34.1) | (29.5) |
| Per Share Data | |||||
| EPS (Basic) | -5.13 | -2.04 | -1.75 | -0.69 | -0.59 |
| EPS (Diluted) | -5.13 | -2.04 | -1.75 | -0.69 | -0.59 |
| Shares Outstanding | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 |
| Metric | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | 237.6 | 8.2 | 14.8 | 24.3 | 5.8 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 8.1 | 2.0 | 2.1 | 0 | 0 |
| Inventory | 6.6 | 3.3 | 2.1 | 0 | 0 |
| Other Current Assets | 1.7 | 0.4 | (1.7) | 1.3 | 0.2 |
| Total Current Assets | 255.3 | 14.9 | 18.4 | 26.2 | 6.2 |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 36.9 | 28.4 | 16.7 | 3.1 | 1.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.5 | 2.7 | 3.5 | 1.2 | 0.6 |
| Total Non-Current Assets | 40.4 | 31.0 | 20.2 | 4.3 | 1.7 |
| Total Assets | 295.7 | 45.9 | 38.7 | 30.5 | 7.9 |
| Current Liabilities | |||||
| Account Payables | 24.0 | 23.9 | 6.2 | 1.7 | 1.8 |
| Short-Term Debt | 0.2 | 0 | 20.4 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.5 | 6.2 | 4.7 | 0 | 0 |
| Total Current Liabilities | 38.0 | 33.0 | 36.7 | 6.6 | 4.0 |
| Non-Current Liabilities | |||||
| Long-Term Debt | 41.1 | 42.5 | 17.3 | 20.2 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.2 | 177.2 | 102.2 | 0.4 | 0 |
| Total Non-Current Liabilities | 52.4 | 222.4 | 119.5 | 22.1 | 0 |
| Total Liabilities | 90.3 | 255.3 | 156.2 | 28.8 | 4.0 |
| Stockholders' Equity | |||||
| Common Stock | 51.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (520.2) | (406.4) | (312.3) | (170.1) | (136.0) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 205.4 | (209.4) | (117.6) | 1.8 | 3.9 |
| Total Liabilities & Equity | 295.7 | 45.9 | 38.7 | 30.5 | 7.9 |
| Debt Metrics | |||||
| Total Debt | 44.3 | 45.2 | 39.1 | 22.8 | 0.5 |
| Net Debt | (193.3) | 36.9 | 24.3 | (1.5) | (5.3) |
| Metric | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | (113.8) | (94.1) | (84.2) | (34.1) | (29.5) |
| Depreciation & Amortization | 8.0 | 11.6 | 4.9 | 0.4 | 0.5 |
| Stock-Based Compensation | 24.3 | 1.5 | 1.2 | 1.9 | 0 |
| Change in Working Capital | (6.2) | 4.4 | 1.3 | (0.0) | (2.0) |
| Other Non-Cash Items | 10.1 | 4.4 | 7.3 | 1.9 | 0.7 |
| Operating Cash Flow | (77.6) | (72.2) | (69.6) | (29.9) | (30.3) |
| Investing Activities | |||||
| Capital Expenditure | (23.6) | (12.5) | (15.5) | (0.3) | (0.2) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0.3 | 0.3 | 0 | 0.0 | 0 |
| Investing Cash Flow | (23.3) | (12.2) | (15.5) | (0.3) | (0.2) |
| Financing Activities | |||||
| Net Debt Issuance | 0 | 5.9 | (5.3) | 20 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (1.7) | (0.8) | (0.7) | (0.2) | (0.2) |
| Other Financing Activities | 12.7 | (2.4) | 0 | 29.0 | 30.4 |
| Financing Cash Flow | 330.3 | 77.7 | 96.1 | 48.8 | 30.2 |
| Cash Position | |||||
| Net Change in Cash | 229.3 | (6.7) | 11.0 | 18.6 | (0.3) |
| Cash at Beginning | 8.6 | 15.3 | 4.3 | 6.3 | 6.6 |
| Cash at End | 237.9 | 8.6 | 15.3 | 24.9 | 6.3 |
| Free Cash Flow | (101.2) | (84.7) | (85.1) | (30.2) | (30.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 59.8 | 27.8 | 7.6 | 0 | 0 |
| Gross Profit | 24.2 | 0.4 | (10.7) | 0 | 0 |
| Operating Income | (106.4) | (85.1) | (80.4) | (32.7) | (29.3) |
| Net Income | (113.8) | (94.1) | (84.2) | (34.1) | (29.5) |
| EPS (Diluted) | -5.13 | -2.04 | -1.75 | -0.69 | -0.59 |
| Balance Sheet | |||||
| Cash & Equivalents | 237.6 | 8.2 | 14.8 | 24.3 | 5.8 |
| Total Assets | 295.7 | 45.9 | 38.7 | 30.5 | 7.9 |
| Total Debt | 44.3 | 45.2 | 39.1 | 22.8 | 0.5 |
| Stockholders' Equity | 205.4 | (209.4) | (117.6) | 1.8 | 3.9 |
| Cash Flow | |||||
| Operating Cash Flow | (77.6) | (72.2) | (69.6) | (29.9) | (30.3) |
| Capital Expenditure | (23.6) | (12.5) | (15.5) | (0.3) | (0.2) |
| Free Cash Flow | (101.2) | (84.7) | (85.1) | (30.2) | (30.5) |